SlideShare a Scribd company logo
Presented by:
Mr. Shaikh Akhil
M.Pharm
Asst. Prof. Dept. of Pharmacology,
BCCO Pharmacy, Naigaon,
S.R.T.M. University, Nanded
ANGINA PECTORIS
 A Chronic disease of CVS
 Occurs with Interminent
chest pain spread along the
Chest, Shoulders and Arms.
Angina- Characterstics sudden severe pressing chest pain
Radiating- neack jaw back arm ( left)
Different from CAD- Angina pectoris, acute syndrome,
arrythmia,short breath
Caused by- decreased O2 in coronary blood flow spasm of ventricle &
muscle
Obstruction of blood vessels by- atheroma
Increase Demand of O2 decrease the supply of O2 ----angina
Angina pectoris: a heart condition marked by paroxysms of chest pain
due to reduced oxygen to the heart
• Angina pectoris, or angina, as it is commonly referred to, and
coronary artery disease or arteriosclerosis are closely related.
• Angina occurs in people who have some form of blockage in the
coronary arteries. In other words, it occurs in people with coronary
heart disease.
ANGINA-CORONARY OCCLUSION
CORONARY OCCLUSION
Types Of Angina Pectoris
1. Stable Angina
2. Unstable Angina
3. Variant Angina (Prinzmetal’s Angina)
STABLE ANGINA
 Predictable
 Occurs on exercise, emotion or eating.
 Caused by increase demand of the heart and by a fixed
narrowing of coronary vessels, almost always by
atheroma.
 Coronary obstruction is ‘fixed’
 Blood flow fails to increase during increased demand
despite the local factors mediated ‘vasodilation’ and so
ischeamic pain is felt.
 So, the diastolic pressure increases and this causes a
endocrinal ‘crunch’ and thus causing Ischeamatic pain
in this region.
 Thus, a form of acutely developing and rapidly
reversible left ventricular failure results which is
relieved by taking rest and reducing the myocardial
workload.
UNSTABLE ANGINA
 This is characterized by Pain that occurs with less
excertion , cumulating pain at rest.
 The pathology is similar to that involved in Myocardial
Infraction, namely platelet-fibrin thrombus associated
with a ruptured atheromatous
plaque, but without complete
occulation of the vessels.
 The risk of infraction is
subtanial, and the main aim
of therapy is to reduce this.
VARIANT ANGINA (PRINZMETAL’S ANGINA)
 Uncommon
 Occurs at rest generally during sleep
 Caused by Large Coronary Artery Spasm
 Usually associated with atheromatous
disease
 Abnormally reactive and
hypertrophied segments
in the Coronary Artery
 Drugs aimed at preventing
& relieving Coronary Spasm.
DIAGNOSIS
1. STRESS (EXERCISE) TEST.
2. ECG (ELECTROCARDIOGRAPHY)
3. CHEST X-RAY
4. CARDIAC ANGIOGRAPHY
5. BLOOD TEST (BIO-MARKERS)
1. EXERCISE TEST/STRESS TEST
 Used to measure heart’s response to exercise
 Patient asked to walk on a treadmill while the
physician takes the ECG
 So any changes in heart function can be determined
 Alternatively the patient recieves an injection of a
radioisotope (generally Thallium) which makes the
heart visible to a special-linked camera
 90% accurate
 But doesn’t identify the exactly where and how the
coronary arteries are blocked.
2. ELECTROCARDIOGRAM (ECG)
 Measures electrical activity of the heart
 Provides info about the changes or damages to the
heart muscle
 Doesn’t detect the narrowing of the coronary arteries
 During an Anginal attack the ECG may show
1. S-T phase depression.
2. T- phase inversion and/or
3. Ventricular arrythmia
 ECG- more abnormal with Unstable Angina where
the elevation in S-T segment is found.
Anti Anginal Drugs
1. Nitrate-
• short acting- Glyceryl trinitrate, isosorbide dinitrate
• Long acting- Isosorbide dinitrate, isosorbide mononitrate
1. Beta blocker- propranolol, metoprolol, atenolol
2. Calcium channel locker- verapamil, diltiazem,
amlodipine
3. Potassium channel opener- nicorandil
4. NA+ channel blocker- Ranolazine
NITRATES
Nitrate-
• short acting- Glyceryl trinitrate, isosorbide dinitrate
• Long acting- Isosorbide dinitrate, isosorbide mononitrate
Nitrates- Nitrate are the vasodilator
1. Nitrates are converted to nitric oxide in the presence of
by-gulutathion-s-transferase & aldehyde reductase
2. Nitric oxide activate the vascular guanylyl cyclase
3. Guanylyl cyclase is increase the synthesis of cAMP( cyclic
guanosine monophosphate)
4. cGMP cause the dephosphorylation of protein kinase
5. This prevent interaction of action with myosin
6. They also decrease free cytosolic calcium
7. The smooth muscle relexation
Mechanism
 Side effects
Headache, Increased mortality, Recurrence of Myocardial
Infraction, Dizziness, Flushing, Rapid heart beat,
Restlessness, Dry mouth, Skin rash, Nausea
PK- nitrates are lipid soluble well absorbed frum buccal
mucous, intestine, skin
Ingested orally
First pass metabolism in liver, half life is longere
• Interaction-
Sildenafil is interact with nitrates cause dangerous- severe
hypotension ( reduce the body oxygen leavel which can
hearts & brain damage
MARKETED FORMULATIONS
 GTN Sorbitrate (PIRAMAL)
 Vasovin (TORRENT)
 ISMO retard (PIRAMAL)
 Angicor (NOVARTIS)
Nitroglyceride
Isosorbide-5-
monophosphate
K + channel opener
 Nicorandil
 open ATP sensitive K+ channel
 hyperpolaraziation
 Relaxation vascular smooth muscle
 se Preload se Afterload se Workload
 Increase coronary dilation
 Decrease angina
 Side effects- flushing, dizziness, palpitation, weakness,
headache, nausea, vomiting
CALCIUM CHANNEL ANTAGONISTS
 types:-
1. Dihydropyridine (amlodipine, nifedipine,
nicardipine)
2. Non-Dihydropyridine
1. Phenylalkylamine (verapamil, gallopamil)
2. Benzodiazapenes (diltiazem)
3. Non-selective (bepridil, mibefradil)
MECHANISM OF ACTION
MARKETED PREPARATIONS
 Calaptin (PIRAMAL)
 Vasopten (TORRENT)
 Coriem XL (RANBAXY)
 Dicard (INTAS)
 Amtas (INTAS)
 Cadeut (PFIZER)
Verapamil
Diltiazem
Amplodipine
Beta blocker - propranolol, metoprolol, atenolol
 Beta blocker inhibit the activation of heart by blocking
Beta 1 receptor
 They reduce of work by the heart rate, contraction,
cardiac output, blood pressure
 The reduce demand of O2 during exercise & rest
 All the blocker are non selective at high dose &
decrease beta 2 receptor
 In classical angina beta blocker + Nitrates is a better
response
 Contraindication in asthma, diabetes, brady cardia
-ADRENOCEPTOR
ANTAGONOSTS
 Important in prophylaxis of angina and treating
unstable angina
 Decrease O2 consumption by the heart
 Effects on coronary vessels-not important
 Avoided in variant angina
 As they increase the chances of spasm
 Eg:-
 Atenolol
 Propranolol
MECHANISM OF ACTION
MARKETED PREPARATIONS
 Betacard ( TORRENT)
 Aten (ZYDUS CADILA)
 Betacap (SUN PHARMA)
 Cardilax (INTAS)
COMBINATION THERAPY
1. Nitrates + -blockers :- in stable angina
2. Ca++ channel blockers + -blockers :-in stable
angina when the treatment with nitrates and -
blockers has failed.
3. Ca++ channel blockers + Nitrates :- in unstable
angina
4. All 3 together:- when the combinations of 2 drugs
has failed, where:-
1. Nitrates:- decrease Preload
2. Ca++ channel Blockers:- decrease Afterload
3. -blockers:- decrease heart rate and myocardial
contractions
THANK YOU!!!!

More Related Content

Similar to Antianginal drug

Anti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa usesAnti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa uses
vijiarumugamvsvs
 
Pharmacology angina
Pharmacology   anginaPharmacology   angina
Pharmacology angina
MBBS IMS MSU
 

Similar to Antianginal drug (20)

14.antianginal drugs
14.antianginal drugs14.antianginal drugs
14.antianginal drugs
 
drugsforanginapectoris-180729002911.pptx
drugsforanginapectoris-180729002911.pptxdrugsforanginapectoris-180729002911.pptx
drugsforanginapectoris-180729002911.pptx
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Antianginal drugs satya
Antianginal drugs satya Antianginal drugs satya
Antianginal drugs satya
 
Drugs used in Cardiac Failure
Drugs used in Cardiac FailureDrugs used in Cardiac Failure
Drugs used in Cardiac Failure
 
CVS-_Angina_Pectoris.pdf
CVS-_Angina_Pectoris.pdfCVS-_Angina_Pectoris.pdf
CVS-_Angina_Pectoris.pdf
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
angina & antianginal drugs.pptx
angina & antianginal drugs.pptxangina & antianginal drugs.pptx
angina & antianginal drugs.pptx
 
Anti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa usesAnti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa uses
 
Class antianginal
Class  antianginalClass  antianginal
Class antianginal
 
Antianginal Drugs.pdf
Antianginal Drugs.pdfAntianginal Drugs.pdf
Antianginal Drugs.pdf
 
Management of Angina Pectoris
Management of Angina PectorisManagement of Angina Pectoris
Management of Angina Pectoris
 
2nd year anti-anginal_drugs
2nd year anti-anginal_drugs2nd year anti-anginal_drugs
2nd year anti-anginal_drugs
 
Anti anginal PPT byVikas gupta
Anti anginal PPT byVikas gupta Anti anginal PPT byVikas gupta
Anti anginal PPT byVikas gupta
 
Antianginals - pharmacology
Antianginals - pharmacologyAntianginals - pharmacology
Antianginals - pharmacology
 
ANTIANGINAL DRUG
ANTIANGINAL DRUGANTIANGINAL DRUG
ANTIANGINAL DRUG
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptxAntianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptx
 
Antianginal drugs
Antianginal drugs Antianginal drugs
Antianginal drugs
 
Pharmacology angina
Pharmacology   anginaPharmacology   angina
Pharmacology angina
 

More from AKHIL SHAIKH (6)

Anti hypertensive drug
Anti hypertensive drugAnti hypertensive drug
Anti hypertensive drug
 
Budget preparation
Budget preparationBudget preparation
Budget preparation
 
Investigational use of drugs
Investigational use of drugsInvestigational use of drugs
Investigational use of drugs
 
Urinary Tract Infection
Urinary Tract InfectionUrinary Tract Infection
Urinary Tract Infection
 
Chemotherapy
Chemotherapy Chemotherapy
Chemotherapy
 
Drugs acting on respiratory system
Drugs acting on respiratory systemDrugs acting on respiratory system
Drugs acting on respiratory system
 

Recently uploaded

Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 

Recently uploaded (20)

GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxGLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on Earth
 
Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
GEOLOGICAL FIELD REPORT On Kaptai Rangamati Road-Cut Section.pdf
GEOLOGICAL FIELD REPORT  On  Kaptai Rangamati Road-Cut Section.pdfGEOLOGICAL FIELD REPORT  On  Kaptai Rangamati Road-Cut Section.pdf
GEOLOGICAL FIELD REPORT On Kaptai Rangamati Road-Cut Section.pdf
 
National Biodiversity protection initiatives and Convention on Biological Di...
National Biodiversity protection initiatives and  Convention on Biological Di...National Biodiversity protection initiatives and  Convention on Biological Di...
National Biodiversity protection initiatives and Convention on Biological Di...
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Transport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSETransport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSE
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
SAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniquesSAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniques
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
Musical Meetups Knowledge Graph (MMKG): a collection of evidence for historic...
Musical Meetups Knowledge Graph (MMKG): a collection of evidence for historic...Musical Meetups Knowledge Graph (MMKG): a collection of evidence for historic...
Musical Meetups Knowledge Graph (MMKG): a collection of evidence for historic...
 
Shuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptxShuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptx
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Topography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of BengalTopography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of Bengal
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 

Antianginal drug

  • 1. Presented by: Mr. Shaikh Akhil M.Pharm Asst. Prof. Dept. of Pharmacology, BCCO Pharmacy, Naigaon, S.R.T.M. University, Nanded
  • 2.
  • 3.
  • 4. ANGINA PECTORIS  A Chronic disease of CVS  Occurs with Interminent chest pain spread along the Chest, Shoulders and Arms.
  • 5. Angina- Characterstics sudden severe pressing chest pain Radiating- neack jaw back arm ( left) Different from CAD- Angina pectoris, acute syndrome, arrythmia,short breath Caused by- decreased O2 in coronary blood flow spasm of ventricle & muscle Obstruction of blood vessels by- atheroma Increase Demand of O2 decrease the supply of O2 ----angina Angina pectoris: a heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart • Angina pectoris, or angina, as it is commonly referred to, and coronary artery disease or arteriosclerosis are closely related. • Angina occurs in people who have some form of blockage in the coronary arteries. In other words, it occurs in people with coronary heart disease.
  • 7. Types Of Angina Pectoris 1. Stable Angina 2. Unstable Angina 3. Variant Angina (Prinzmetal’s Angina)
  • 8. STABLE ANGINA  Predictable  Occurs on exercise, emotion or eating.  Caused by increase demand of the heart and by a fixed narrowing of coronary vessels, almost always by atheroma.  Coronary obstruction is ‘fixed’  Blood flow fails to increase during increased demand despite the local factors mediated ‘vasodilation’ and so ischeamic pain is felt.
  • 9.  So, the diastolic pressure increases and this causes a endocrinal ‘crunch’ and thus causing Ischeamatic pain in this region.  Thus, a form of acutely developing and rapidly reversible left ventricular failure results which is relieved by taking rest and reducing the myocardial workload.
  • 10. UNSTABLE ANGINA  This is characterized by Pain that occurs with less excertion , cumulating pain at rest.  The pathology is similar to that involved in Myocardial Infraction, namely platelet-fibrin thrombus associated with a ruptured atheromatous plaque, but without complete occulation of the vessels.  The risk of infraction is subtanial, and the main aim of therapy is to reduce this.
  • 11. VARIANT ANGINA (PRINZMETAL’S ANGINA)  Uncommon  Occurs at rest generally during sleep  Caused by Large Coronary Artery Spasm  Usually associated with atheromatous disease  Abnormally reactive and hypertrophied segments in the Coronary Artery  Drugs aimed at preventing & relieving Coronary Spasm.
  • 12. DIAGNOSIS 1. STRESS (EXERCISE) TEST. 2. ECG (ELECTROCARDIOGRAPHY) 3. CHEST X-RAY 4. CARDIAC ANGIOGRAPHY 5. BLOOD TEST (BIO-MARKERS)
  • 13. 1. EXERCISE TEST/STRESS TEST  Used to measure heart’s response to exercise  Patient asked to walk on a treadmill while the physician takes the ECG  So any changes in heart function can be determined  Alternatively the patient recieves an injection of a radioisotope (generally Thallium) which makes the heart visible to a special-linked camera  90% accurate  But doesn’t identify the exactly where and how the coronary arteries are blocked.
  • 14. 2. ELECTROCARDIOGRAM (ECG)  Measures electrical activity of the heart  Provides info about the changes or damages to the heart muscle  Doesn’t detect the narrowing of the coronary arteries  During an Anginal attack the ECG may show 1. S-T phase depression. 2. T- phase inversion and/or 3. Ventricular arrythmia  ECG- more abnormal with Unstable Angina where the elevation in S-T segment is found.
  • 15. Anti Anginal Drugs 1. Nitrate- • short acting- Glyceryl trinitrate, isosorbide dinitrate • Long acting- Isosorbide dinitrate, isosorbide mononitrate 1. Beta blocker- propranolol, metoprolol, atenolol 2. Calcium channel locker- verapamil, diltiazem, amlodipine 3. Potassium channel opener- nicorandil 4. NA+ channel blocker- Ranolazine
  • 16.
  • 17. NITRATES Nitrate- • short acting- Glyceryl trinitrate, isosorbide dinitrate • Long acting- Isosorbide dinitrate, isosorbide mononitrate Nitrates- Nitrate are the vasodilator 1. Nitrates are converted to nitric oxide in the presence of by-gulutathion-s-transferase & aldehyde reductase 2. Nitric oxide activate the vascular guanylyl cyclase 3. Guanylyl cyclase is increase the synthesis of cAMP( cyclic guanosine monophosphate) 4. cGMP cause the dephosphorylation of protein kinase 5. This prevent interaction of action with myosin 6. They also decrease free cytosolic calcium 7. The smooth muscle relexation
  • 19.  Side effects Headache, Increased mortality, Recurrence of Myocardial Infraction, Dizziness, Flushing, Rapid heart beat, Restlessness, Dry mouth, Skin rash, Nausea PK- nitrates are lipid soluble well absorbed frum buccal mucous, intestine, skin Ingested orally First pass metabolism in liver, half life is longere • Interaction- Sildenafil is interact with nitrates cause dangerous- severe hypotension ( reduce the body oxygen leavel which can hearts & brain damage
  • 20. MARKETED FORMULATIONS  GTN Sorbitrate (PIRAMAL)  Vasovin (TORRENT)  ISMO retard (PIRAMAL)  Angicor (NOVARTIS) Nitroglyceride Isosorbide-5- monophosphate
  • 21. K + channel opener  Nicorandil  open ATP sensitive K+ channel  hyperpolaraziation  Relaxation vascular smooth muscle  se Preload se Afterload se Workload  Increase coronary dilation  Decrease angina  Side effects- flushing, dizziness, palpitation, weakness, headache, nausea, vomiting
  • 22. CALCIUM CHANNEL ANTAGONISTS  types:- 1. Dihydropyridine (amlodipine, nifedipine, nicardipine) 2. Non-Dihydropyridine 1. Phenylalkylamine (verapamil, gallopamil) 2. Benzodiazapenes (diltiazem) 3. Non-selective (bepridil, mibefradil)
  • 24. MARKETED PREPARATIONS  Calaptin (PIRAMAL)  Vasopten (TORRENT)  Coriem XL (RANBAXY)  Dicard (INTAS)  Amtas (INTAS)  Cadeut (PFIZER) Verapamil Diltiazem Amplodipine
  • 25. Beta blocker - propranolol, metoprolol, atenolol  Beta blocker inhibit the activation of heart by blocking Beta 1 receptor  They reduce of work by the heart rate, contraction, cardiac output, blood pressure  The reduce demand of O2 during exercise & rest  All the blocker are non selective at high dose & decrease beta 2 receptor  In classical angina beta blocker + Nitrates is a better response  Contraindication in asthma, diabetes, brady cardia
  • 26. -ADRENOCEPTOR ANTAGONOSTS  Important in prophylaxis of angina and treating unstable angina  Decrease O2 consumption by the heart  Effects on coronary vessels-not important  Avoided in variant angina  As they increase the chances of spasm  Eg:-  Atenolol  Propranolol
  • 28. MARKETED PREPARATIONS  Betacard ( TORRENT)  Aten (ZYDUS CADILA)  Betacap (SUN PHARMA)  Cardilax (INTAS)
  • 29. COMBINATION THERAPY 1. Nitrates + -blockers :- in stable angina 2. Ca++ channel blockers + -blockers :-in stable angina when the treatment with nitrates and - blockers has failed. 3. Ca++ channel blockers + Nitrates :- in unstable angina 4. All 3 together:- when the combinations of 2 drugs has failed, where:- 1. Nitrates:- decrease Preload 2. Ca++ channel Blockers:- decrease Afterload 3. -blockers:- decrease heart rate and myocardial contractions